2cureX AB (publ) (STO:2CUREX)

2cureX AB Statistics

Total Valuation

2cureX AB has a market cap or net worth of SEK 34.64 million. The enterprise value is 31.51 million.

Market Cap	34.64M
Enterprise Value	31.51M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	Jun 27, 2025

Share Statistics

2cureX AB has 25.10 million shares outstanding.

Current Share Class	25.10M
Shares Outstanding	25.10M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.53
PB Ratio	12.44
P/TBV Ratio	12.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.20
EV / Sales	15.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.39

Financial Position

The company has a current ratio of 1.51

Current Ratio	1.51
Quick Ratio	1.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.77

Financial Efficiency

Return on equity (ROE) is -174.78% and return on invested capital (ROIC) is -119.66%.

Return on Equity (ROE)	-174.78%
Return on Assets (ROA)	-97.99%
Return on Invested Capital (ROIC)	-119.66%
Return on Capital Employed (ROCE)	-1,036.19%
Revenue Per Employee	141,143
Profits Per Employee	-1.88M
Employee Count	14
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	-4.63M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +304.17% in the last 52 weeks. The beta is 1.46, so 2cureX AB's price volatility has been higher than the market average.

Beta (5Y)	1.46
52-Week Price Change	+304.17%
50-Day Moving Average	1.09
200-Day Moving Average	1.95
Relative Strength Index (RSI)	66.12
Average Volume (20 Days)	298,360

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, 2cureX AB had revenue of SEK 1.98 million and -26.35 million in losses. Loss per share was -1.50.

Revenue	1.98M
Gross Profit	-7.63M
Operating Income	-28.86M
Pretax Income	-30.98M
Net Income	-26.35M
EBITDA	-28.62M
EBIT	-28.86M
Loss Per Share	-1.50

Balance Sheet

The company has 3.13 million in cash and n/a in debt, with a net cash position of 3.13 million or 0.12 per share.

Cash & Cash Equivalents	3.13M
Total Debt	n/a
Net Cash	3.13M
Net Cash Per Share	0.12
Equity (Book Value)	2.79M
Book Value Per Share	0.16
Working Capital	2.18M

Cash Flow

In the last 12 months, operating cash flow was -22.59 million and capital expenditures -17,000, giving a free cash flow of -22.61 million.

Operating Cash Flow	-22.59M
Capital Expenditures	-17,000
Free Cash Flow	-22.61M
FCF Per Share	-0.90

Margins

Gross Margin	n/a
Operating Margin	-1,460.43%
Pretax Margin	-1,567.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 4.43%.

Dividend Per Share	0.08
Dividend Yield	4.43%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	4.43%
Earnings Yield	-76.05%
FCF Yield	-65.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

2cureX AB has an Altman Z-Score of -9.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.46
Piotroski F-Score	2